as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
1.00%
Downside
0.28%
Upside
52 Week's Low
52 Week's High
35.72%
Downside
26.71%
Upside
Check Exelixis, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.5B
EPS (TTM)
2.7082
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.16%
PE Ratio (TTM)
18.78
Industry PE ratio
10.127857142857144
P/B Ratio
18.7837
PEG Ratio
2.2685
EBITDA
781.5M
Revenue (TTM)
2.2B
Profit Margin
27.01%
Return On Equity TTM
29.00%
Track how Exelixis, Inc. P/E has moved over time to understand its valuation trends.
Exelixis, Inc. in the last 5 years
Lowest (15.15x)
September 30, 2024
Industry (10.13x)
September 12, 2025
Today (18.78x)
September 12, 2025
Highest (122.74x)
April 30, 2021
Today’s Price to Earnings Ratio: 18.78x
Compare market cap, revenue, PE, and other key metrics of Exelixis, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $10.5B | 79.8% | 18.78 | 27.01% | |
BUY | $61.5B | 282.7% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.9B | 54.04% | 28.24 | 31.86% | |
BUY | $59.2B | 2.03% | 14.33 | 31.37% |
The Exelixis, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Exelixis, Inc. investment value today
Current value as on today
₹1,53,956
Returns
₹53,956
(+53.96%)
Returns from Exelixis, Inc. Stock
₹48,841 (+48.84%)
Dollar Returns*
₹5,115 (+5.12%)
Based on 26 analysts
76.92%
Buy
19.23%
Hold
3.85%
Sell
Based on 26 analysts, 76.92% of analysts recommend a 'BUY' rating for Exelixis, Inc.. Average target price of $44.06
Get share price movements and forecasts by analysts on Exelixis, Inc..
What analysts predicted
11.12%UPSIDE
Target Price
$44.06
Current Price
$39.16
Analyzed by
26 Analysts
Target
$44.06
Exelixis, Inc. target price $44.06, a slight upside of 11.12% compared to current price of $39.16. According to 26 analysts rating.
Search interest for Exelixis, Inc. Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:23% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 year, EXEL stock has moved up by 47.7%
Profit Spike
Netprofit is up for the last 4 quarters, 117.97M → 184.84M (in $), with an average increase of 13.9% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 555.44M → 568.26M (in $), with an average increase of 2.3% per quarter
Best in 3 Years
In the last 3 years, EXEL has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.6% return, outperforming this stock by 28.9%
Organisation | Exelixis, Inc. |
Headquarters | 1851 Harbor Bay Parkway, Alameda, CA, United States, 94502 |
Industry | Health Technology |
CEO | Dr. Michael M. Morrissey Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Jeffrey J. Hessekiel J.D. | Executive VP & General Counsel |
Dr. William Berg M.D. | Senior Vice President of Medical Affairs |
Dr. Stefan Krauss Ph.D. | VP & Head of Business Development |
Dr. Dana T. Aftab Ph.D. | Executive Vice President of Research & Development |
Ms. Susan T. Hubbard | Executive Vice President of Public Affairs & Investor Relations |
Dr. Anne Champsaur M.D. | Senior Vice President of Drug Safety |
Mr. Patrick Joseph Haley M.B.A. | Executive Vice President of Commercial |
Dr. Stelios Papadopoulos Ph.D. | Co-Founder & Independent Chair of the Board |
Dr. Michael M. Morrissey Ph.D. | CEO, President & Director |
Mr. Christopher J. Senner | Executive VP & CFO |
Exelixis, Inc. share price today is $39.16 as on at the close of the market. Exelixis, Inc. share today touched a day high of $39.27 and a low of $38.77.
Exelixis, Inc. share touched a 52 week high of $49.62 on and a 52 week low of $25.17 on . Exelixis, Inc. stock price today i.e. is closed at $39.16,which is 21.08% down from its 52 week high and 55.56% up from its 52 week low.
Exelixis, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Exelixis, Inc. (EXEL) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Exelixis, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Exelixis, Inc. share’s latest price of $39.16 as on September 13, 2025 at 1:29 am IST, you will get 0.2554 shares of Exelixis, Inc.. Learn more about
fractional shares .
Exelixis, Inc. stock has given 79.8% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?